Skip to main content
. 2015 Dec 14;21(46):13124–13131. doi: 10.3748/wjg.v21.i46.13124

Table 2.

Outcomes of 1-wk and 2-wk moxifloxacin-containing triple therapy n (%)

1-wk MCT 2-wk MCT P value
Eradication rate
Intention-to-treat 34 (56.7) 29 (76.3) 0.048
Per-protocol 34 (59.6) 29 (80.6) 0.036
Compliance 57 (95.0) 36 (94.9) 0.954
Side effects 12 (21.1) 5 (13.9) 0.384
Nausea 5 (11.6) 0 0.178
Dyspepsia 4 (7.0) 1 (2.8)
Epigastric soreness 2 (3.5) 1 (2.8)
Diarrhea 1 (1.8) 3 (8.3)

MCT: Moxifloxacin-containing triple therapy.